Grafa
Tech
dorsaVi licenses NTU IP to boost robotics strategy
Image for illustrative purposes only. Not a real photo.

dorsaVi licenses NTU IP to boost robotics strategy

Share

dorsaVi (ASX:DVL) has entered into an agreement to license two breakthrough robotics intellectual property assets from Nanyang Technological University, Singapore.

The acquisition is set to accelerate dorsaVi’s expansion into collaborative robotics, rehabilitation exoskeletons, autonomous industrial systems, and human-machine interface platforms.

The licensed IP features two core innovations designed to bridge the gap between human movement and advanced automation.

Invention 1 introduces a patented control system that allows robots to operate safely alongside humans in real time—a critical hurdle that has historically restricted the widespread adoption of cobots in the healthcare, manufacturing, and defence sectors.

Invention 2 utilizes dorsaVi’s extensive clinical sensor data to establish a high-quality training library, allowing robotic systems to learn from real-world human movement and become significantly faster and more adaptive.

The NTU IP perfectly complements dorsaVi’s existing V6.5 on-sensor intelligence platform, combining validated clinical data with a robust safety control framework.

Supported by the company’s validated RRAM memory and neuromorphic chip technologies, this integration delivers a projected 10x gain in on-device AI inference with ultra-low power consumption, enabling real-time edge decision-making without cloud dependency.

By securing these safety control and data intelligence layers, dorsaVi effectively completes its vertically integrated robotics intelligence stack, controlling everything from sensing and memory to compute and safety.

Frequently asked questions

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.